IRLAB Therapeutics AB (publ) (STO:IRLAB.A)

Sweden · Delayed Price · Currency is SEK

1.270

-0.004 (-0.31%)

Jul 24, 2026, 5:29 PM CET

IRLAB Therapeutics AB Financials Overview

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	95.24	62.8	114.08	5.72	61.28	207.91
Revenue Growth	-22.02%	-44.95%	1894.46%	-90.66%	-70.53%	51361.88%
Gross Profit	95.24	62.8	114.08	5.72	61.28	207.91
Operating Income	-54.03	-93.4	-75.11	-180.77	-113.11	52.58
Net Income	-66.92	-110.01	-83.13	-177.84	-113.41	51.78
Earnings Per Share	-1.04	-1.64	-1.60	-3.43	2.19	1.00
EPS Growth	-	-	-	-	119.00%	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	50.79	81.86	66.92	111.31	252.78	401.9
Total Debt	27.08	29.95	60.42	27.57	3.98	6.6
Net Cash (Debt)	23.7	51.91	6.5	83.74	248.8	395.3
Net Cash Growth	7.04%	699.06%	-92.24%	-66.34%	-37.06%	44.23%
Net Cash Per Share	0.32	0.77	0.13	1.61	4.80	7.64

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-90.23	-55.22	-65.59	-164.85	-142.61	128.64
Capital Expenditures	-	-	-0.2	-0.29	-2.88	-0.71
Free Cash Flow	-90.23	-55.22	-65.79	-165.14	-145.49	127.93
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-56.73%	-148.73%	-65.84%	-3160.23%	-184.59%	25.29%
Pretax Margin	-70.26%	-175.18%	-72.87%	-3109.07%	-185.07%	24.91%
Profit Margin	-70.26%	-175.18%	-72.87%	-3109.07%	-185.07%	24.91%
FCF Margin	-94.74%	-87.93%	-57.67%	-2887.12%	-237.43%	61.53%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	17.49	44.00
Forward PE	-	4.43	-	-	-	-
P/FCF Ratio	-	-	-	-	-	17.80
PS Ratio	2.05	2.66	4.89	68.01	32.42	10.95